Pharmaceutical and Healthcare Sciences Society Annual Members Conference (PHSS)2014

As new Biological products, challenging toxic products and Cellular/ Gene therapies (ATMPs) are developed there are increasing challenges in GMP compliance. With more complex products that have increased efficacy and efficiency in targeted delivery systems the challenges in processing and GMP compliance with a focus on patient safety require new strategies, technologies and practice.